LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Advances Cancer Drug In EU With EMA Application Validation

AstraZeneca (LSE:AZN) recently saw its stock price increase by 9% over the last quarter, a move potentially influenced by the European Medicines Agency's validation of its ENHERTU® marketing authorization application. This development complements other significant news, such as the favorable TAGRISSO trial results and regulatory approvals for DATROWAY, which could have added positive momentum. Amid these corporate achievements, broader market trends saw the Nasdaq hitting new highs,...
AIM:ALT
AIM:ALTSoftware

UK Penny Stocks To Watch In September 2025

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting ongoing global economic uncertainties. Despite these broader market pressures, penny stocks continue to capture investor interest as they represent opportunities in smaller or newer companies that may offer significant growth potential. While the term "penny stock" might seem outdated, these investments can still provide value when...